Global Sickle Cell Disease Treatment Market Report By Type (Infection Prevention With Vaccination And Antibiotics, Blood Transfusion, The Medication Hydroxycarbamide, And A Transplant Of Bone Marrow Cells), Application (Hospitals, Ambulatory Surgical Centers, Clinics, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210465
February 2019
Report Formats:

As per this study, the Global Sickle Cell Disease Treatment Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Sickle cell disease is a hereditary blood disorder characterized by rigid, abnormal, sickle-shaped red blood cells (RBCs). It is caused due to a mutation in beta-globin gene. The current treatment for sickle cell disease (SCD) consists of hydroxycarbamide and blood transfusion treatment. Most of the patients suffering from SCD are blood transfusion dependent and the only potential curative treatment for SCD is Bone Marrow Transplant (BMT).
 
Market Dynamics
 
The growing patient pool and high unmet medical needs are the key factors for the sickle cell disease treatment (SCD) market growth. Moreover, increasing investment by the government in order to improve the healthcare services are again pushing the market growth. However, the high cost of treatment and unavailability of required drugs are some of the factors that hinder the market growth. Whereas increasing support from government and regulatory bodies by means of research and development and approval of discovering a newer treatment for SCD disorder are some growth factors expected to drive the SCD market during the forecast period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of sickle cell disease treatment.
 
Market Segmentation
 
The broad sickle cell disease treatment market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Infection Prevention with Vaccination and Antibiotics
  • Blood Transfusion
  • The Medication Hydroxycarbamide
  • A Transplant of Bone Marrow Cells
 
By Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for sickle cell disease treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Sickle Cell Disease Treatment Market By Revenue (USD MN)
 
Europe Sickle Cell Disease Treatment Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Sickle Cell Disease Treatment market include Acceleron Pharma, Alnylam Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Baxter, Bluebird Bio, Bristol-Myers Squibb, Eli Lilly, Emmaus Life Sciences, Global Blood Therapeutics Novartis, Pfizer, Sangamo Therapeutics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Sickle Cell Disease Treatment
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Sickle Cell Disease Treatment Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY TYPE
  • Sickle Cell Disease Market In Infection Prevention with Vaccination and Antibiotics
  • Sickle Cell Disease Market In Blood Transfusion
  • Sickle Cell Disease Market In The Medication Hydroxycarbamide
  • Sickle Cell Disease Market In A Transplant of Bone Marrow Cells
 
5. SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY APPLICATION
  • Sickle Cell Disease Market In Hospitals
  • Sickle Cell Disease Market In Ambulatory Surgical Centers
  • Sickle Cell Disease Market In Clinics
  • Sickle Cell Disease Market In Others
 
6. SICKLE CELL DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE SICKLE CELL DISEASE TREATMENT COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE SICKLE CELL DISEASE TREATMENT INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Acceleron Pharma
  • Alnylam Pharmaceuticals
  • Arena Pharmaceuticals
  • AstraZeneca
  • Baxter
  • Bluebird Bio
  • Bristol-Myers Squibb
  • Eli Lilly
  • Emmaus Life Sciences
  • Global Blood Therapeutics Novartis
  • Pfizer
  • Sangamo Therapeutics
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Sickle Cell Disease Treatment
Table 2.  Global Sickle Cell Disease Treatment Market By Types
Table 3.  Global Sickle Cell Disease Treatment Market By Application
Table 4.  Global Sickle Cell Disease Treatment Market By Geography
Table 5.  North America Sickle Cell Disease Treatment Market
Table 6.  Europe Sickle Cell Disease Treatment Market
Table 7.  Asia Pacific Sickle Cell Disease Treatment Market
Table 8.  Latin America Sickle Cell Disease Treatment Market
Table 9.  Middle East And Africa Sickle Cell Disease Treatment Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Sickle Cell Disease Treatment Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Sickle Cell Disease Treatment
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Sickle Cell Disease Treatment Market By Types
Fig. 10.   Global Sickle Cell Disease Treatment Market By Application
Fig. 11.   Global Sickle Cell Disease Treatment Market By Geography
Fig. 12.   North America Sickle Cell Disease Treatment Market
Fig. 13.   Europe Sickle Cell Disease Treatment Market
Fig. 14.   Asia Pacific Sickle Cell Disease Treatment Market
Fig. 15.   Latin America Sickle Cell Disease Treatment Market
Fig. 16.   Middle East And Africa Sickle Cell Disease Treatment Market
Fig. 17.   Market Share Of Sickle Cell Disease Treatment Companies
Fig. 18.   Recent Developments In Sickle Cell Disease Treatment Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials